SCHEMBL5599645

SCHEMBL5599645

O=C(C(c1ccccc1)c1ccccc1)N1CC2(CCNCC2)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 4/20 0.51
ROCK2 O75116 1/20 0.45
ROCK1 Q13464 1/20 0.45
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
AKT1 P31749 4/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
USP2 O75604 3/20 0.40
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
P2RY1 P47900 1/20 0.39
CYP2C19 P33261 1/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1572534 0.84 NOTUM (0.63) NOTUMROCK2ROCK1AKT1HDAC1
SCHEMBL30232786 0.84 NOTUM (0.63) NOTUMROCK2ROCK1AKT1HDAC1
SCHEMBL14366457 0.80 HDAC1 (0.57) NOTUMROCK2ROCK1HTTAKT1
SCHEMBL655024 0.80 NOTUM (0.80) NOTUMROCK2ROCK1AKT1HDAC1
Hydrochloric Acid SCHEMBL2257588 0.79 NOTUM (0.78) NOTUMROCK2ROCK1AKT1HDAC1
SCHEMBL5578548 0.78 SIGMAR1 (0.49) NOTUMHDAC1HDAC6
SCHEMBL5578692 0.78 SIGMAR1 (0.52) NOTUMHDAC1HDAC6
SCHEMBL5578840 0.78 DPP9 (0.44) MEN1HTTKMT2ANPSR1USP2
SCHEMBL14529913 0.76 NOTUM (0.57) NOTUMROCK2ROCK1AKT1HDAC1
SCHEMBL6544407 0.76 NOTUM (0.57) NOTUMROCK2ROCK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005063745-A9 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARM INC (US) 2007-02-01 WO claimed
EP-1716148-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF Arena Pharmaceuticals, Inc. (US) 2006-11-02 EP claimed
WO-2005063745-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2005-07-14 WO claimed